OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Download original image

Fig. 2. Steps in the process of CAR T-cell therapy. (1) Physicians should select patients who are appropriate for CAR T-cell therapy. (2) Autologous T cells should be collected via a qualified process. (3) Patients may need various bridging therapies during CAR T-cell manufacturing. (4) Patients receive CAR T cells after lymphodepletion chemotherapy, and the CAR T-cell therapy center should establish standardized protocols for monitoring and managing toxicities after CAR T-cell therapy.
Abbreviation: CAR, chimeric antigen receptor.
Ann Lab Med 2024;44:210~221 https://doi.org/10.3343/alm.2023.0388

© Ann Lab Med